Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 4:2017:16-0142.
doi: 10.1530/EDM-16-0142. eCollection 2017.

Cerebral salt wasting following traumatic brain injury

Affiliations

Cerebral salt wasting following traumatic brain injury

Peter Taylor et al. Endocrinol Diabetes Metab Case Rep. .

Abstract

Summary: Hyponatraemia is the most commonly encountered electrolyte disturbance in neurological high dependency and intensive care units. Cerebral salt wasting (CSW) is the most elusive and challenging of the causes of hyponatraemia, and it is vital to distinguish it from the more familiar syndrome of inappropriate antidiuretic hormone (SIADH). Managing CSW requires correction of the intravascular volume depletion and hyponatraemia, as well as mitigation of on-going substantial sodium losses. Herein we describe a challenging case of CSW requiring large doses of hypertonic saline and the subsequent substantial benefit with the addition of fludrocortisone.

Learning points: The diagnosis of CSW requires a high index of suspicion. Distinguishing it from SIADH is essential to enable prompt treatment in order to prevent severe hyponatraemia.The hallmarks of substantial CSW are hyponatraemia, reduced volume status and inappropriately high renal sodium loss.Substantial volumes of hypertonic saline may be required for a prolonged period of time to correct volume and sodium deficits.Fludrocortisone has a role in the management of CSW. It likely reduces the doses of hypertonic saline required and can maintain serum sodium levels of hypertonic saline.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Serum sodium, urine sodium and daily intravenous sodium.

References

    1. Peters JP, Welt LG, Sims EA, Orloff J, Needham J. 1950. A salt-wasting syndrome associated with cerebral disease. Transactions of the Association of American Physicians 63 57–64. - PubMed
    1. Berendes E, Walter M, Cullen P, Prien T, Van Aken H, Horsthemke J, Schulte M, von Wild K, Scherer R. 1997. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 349 245–249. (10.1016/S0140-6736(96)08093-2) - DOI - PubMed
    1. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, et al. 2014. Clinical practice guideline on diagnosis and treatment of hyponatraemia. European Journal of Endocrinology 170 G1–G47. (10.1530/EJE-13-1020) - DOI - PubMed
    1. Tomida M, Muraki M, Uemura K, Yamasaki K. 1998. Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke 29 1584–1587. (10.1161/01.STR.29.8.1584) - DOI - PubMed
    1. Yee AH, Burns JD, Wijdicks EF. 2010. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurgery Clinics of North America 21 339–352. (10.1016/j.nec.2009.10.011) - DOI - PubMed

LinkOut - more resources